ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Estimated per-act risk for acquisition of HIV, by exposure route

Estimated per-act risk for acquisition of HIV, by exposure route
Exposure route Risk per 10,000 exposures to an infected source (risk)
Blood-borne exposure Blood transfusion 9000 (9/10)
Needle-sharing injection drug use 67 (1/150)
Percutaneous needle stick 23 (1/435)
Mucous membrane exposure to blood (eg, splash to eye) 10 (1/1000)
Sexual exposure Receptive anal intercourse 138 (1/72)
Insertive anal intercourse 11 (1/900)
Receptive penile-vaginal intercourse 8 (1/1250)
Insertive penile-vaginal intercourse 4 (1/2500)
Receptive or insertive penile-oral intercourse 0-4
Other Biting, spitting, throwing body fluids (including semen and saliva), sharing sex toys Negligible
There are scant empiric data on per contact risk of exposure. This table lists the estimated risk by exposure type in the absence of antiretroviral treatment of the HIV-infected source and in the absence of amplifying factors. Most of these estimates are derived through modeling studies of different cohorts. Clinicians need to be aware that estimates of sexual risk are often based on studies of monogamous couples among whom amplifying factors have been treated and repeated exposure may offer as yet unexplained protection from infection. Using a single value for assessing risk of HIV transmission based on route of sexual exposure fails to reflect the variation associated with important cofactors. A variety of amplifying factors and conditions have been identified, and these factors can be expected to increase transmission probability.
Data from:
  1. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990; 113:733-9.
  2. Baggaley RF, Boily MC, White RG, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: A systematic review and meta-analysis. AIDS 2006; 20:805.
  3. Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr 1995; 10:175-6.
  4. Patel P, Borkowf CB, Brooks JT, et al. Estimating per-act HIV transmission risk: A systematic review. AIDS 2014; 28:1509-19.
  5. Cohen MS. Amplified transmission of HIV-1: Missing link in the HIV pandemic. Trans Am Clin Climatol Assoc 2006; 117: 213–225.
  6. Centers for Disease Control and Prevention, US Department of Health and Human Services. Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016.
Graphic 60145 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟